Cannabidiol (CBD) derived from legal hemp (aka Cannabis with no more than 0.300% delta-9-THC) is a complex molecule that has been shown to offer a high therapeutic potential for a variety of ailments. Unfortunately, there are also potential drug contraindications that, if not carefully managed, could result in serious medical complications. To review which conditions healthcare professionals are currently exploring the use of CBD to relieve, click here.
Blaze Therapeutics is a Responsible Distribution organization dedicated to making the open market safer for medically complex individuals. This requires that healthcare providers are educated regarding the biomolecular mechanisms of action of phytocannabinoids and the pharmacological mechanism of action of Cannabis-derived products, amongst other key considerations for clinical intervention.
Designed to meet the demands of a busy schedule, an electronic version of the Cannabis Medicine Guide for Healthcare Professionals is provided for immediate download upon purchase of first wholesale order, allowing for review and study at one's own pace.
What participants learn:
The Pharmacology of the Endocannabinoid System (ECS)
The Pharmacology and clinical applications of phytocannabinoids
Summaries of the Clinical Evidence for the Implementation of Cannabis into Medical Practice & Precautions
Cannabis Taxonomy and the difference between Hemp and Marijuana
Appropriately dosing patients with key considerations
Blaze Therapeutics is dedicated to serving and protecting the medically complex community. Blaze Therapeutics encourages all healthcare professionals interested in incorporating Cannabis into their practice, consulting business, educational presentations, etc., to only distribute Responsibly or to refer their patients to consume Responsibly.
Blaze Therapeutics is the ONLY Responsible Distribution company currently incorporated in the world (2021).